Amyloid cardiomyopathy: сlinical significance and diagnostic value of magnetic resonance imaging
Open Access
- 23 November 2024
- journal article
- Published by Intermedservice Ltd in Eurasian heart journal
- No. 4,p. 90-97
Abstract
The incidence and prevalence of amyloid cardiomyopathy (AC) has been increasing in recent years, and this diagnosis is often detected at the final stage. This determines late prescription of specific therapy and worsening prognosis of patients. Unfortunately, doctors are not sufficiently informed about the pathogenesis of AC and diagnostic methods. This circumstance leads to prolongation of time from the manifestation of the disease to the diagnosis. Despite the presence of a large number of AC masks, a number of specific clinical diagnostic markers called «red flags» helps to suspect AC. In addition, the development of diagnostic algorithms using non-invasive imaging methods can help not only in diagnosing AC at an early stage of the disease, but also in determining the type of amyloidosis, that determines the success of timely administration of disease-modifying therapy. The aim of this review is to analyze the possibility of using MRI criteria to attempt non-invasive typing of amyloidosis and to differentiate ATTR and AL AС.Keywords
This publication has 29 references indexed in Scilit:
- Diagnostic and Prognostic Value of Non-late Gadolinium Enhancement Cardiac Magnetic Resonance Parameters in Cardiac AmyloidosisCurrent Problems in Cardiology, 2022
- Myocardial Tissue Characterization by Combining Extracellular Volume Fraction and T2 MappingJACC: Cardiovascular Imaging, 2022
- Echocardiographic and Clinical Predictors of Cardiac Amyloidosis: Limitations of Apical SparingESC Heart Failure, 2021
- Diagnosis and treatment of cardiac amyloidosis: position statement of the German Cardiac Society (DGK)Clinical Research in Cardiology, 2021
- Native T1 Mapping, Extracellular Volume Mapping, and Late Gadolinium Enhancement in Cardiac AmyloidosisJACC: Cardiovascular Imaging, 2020
- ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2—evidence base and standardized methods of imagingJournal of Nuclear Cardiology, 2019
- Myocardial Edema and Prognosis in AmyloidosisJACC, 2018
- Magnetic Resonance in Transthyretin Cardiac AmyloidosisJACC, 2017
- CMR-Based Differentiation of AL and ATTR Cardiac AmyloidosisJACC: Cardiovascular Imaging, 2014
- Noncontrast T1 Mapping for the Diagnosis of Cardiac AmyloidosisJACC: Cardiovascular Imaging, 2013